Literature DB >> 18406373

New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles.

Esther Wilk1, Katy Kalippke, Sabine Buyny, Reinhold E Schmidt, Roland Jacobs.   

Abstract

Natural killer (NK) cells represent important early effector cells of the innate immune system. They can lyse virally infected and malignant cells without prior sensitization, making them important members of the first line of defense. In addition, they participate in the regulation of immune responses and hematopoiesis by producing various cytokines and chemokines. These different functional capacities can to some extent be assigned to distinct NK cell populations. In humans, CD56(dim) NK cells featuring strong cytotoxic capacity can be easily distinguished from CD56(bright) NK cells, which predominantly produce cytokines and exert only marginal cytotoxicity. Murine NK cells lack CD56 expression and no correlate marker enabling identification of functional subpopulations has been described. Here, we summarize and discuss human NK cell populations in greater detail in order to evaluate their regulatory capacity and to detect alternative and distinctive markers, e.g. CXCR3 and CD27, which are shared by both humans and mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18406373     DOI: 10.1016/j.imbio.2007.10.012

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  16 in total

Review 1.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

Review 2.  Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Authors:  V I Seledtsov; A G Goncharov; G V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

4.  Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.

Authors:  Guido Beldi; Yara Banz; Alexander Kroemer; Xiaofeng Sun; Yan Wu; Nadine Graubardt; Alyssa Rellstab; Martina Nowak; Keiichi Enjyoji; Xian Li; Wolfgang G Junger; Daniel Candinas; Simon C Robson
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function.

Authors:  Alexander Vargas-Hernández; Agnieszka Witalisz-Siepracka; Michaela Prchal-Murphy; Klara Klein; Sanjana Mahapatra; Waleed Al-Herz; Emily M Mace; Alexandre F Carisey; Jordan S Orange; Veronika Sexl; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2019-10-07       Impact factor: 10.793

6.  Molecular Mechanisms of Interaction Between Human Immune Cells and Far Eastern Tick-Borne Encephalitis Virus Strains.

Authors:  Natalya V Krylova; Tatiana P Smolina; Galina N Leonova
Journal:  Viral Immunol       Date:  2015-02-19       Impact factor: 2.257

7.  Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.

Authors:  Y Yamada; Y Okubo; A Shimada; Y Oikawa; S Yamada; S Narumi; K Matsushima; H Itoh
Journal:  Diabetologia       Date:  2012-04-11       Impact factor: 10.122

8.  NK cell maturation and function in C57BL/6 mice are altered by caloric restriction.

Authors:  Jonathan F Clinthorne; Eleni Beli; David M Duriancik; Elizabeth M Gardner
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

9.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

10.  Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12.

Authors:  Amanda R Campbell; Kelly Regan; Neela Bhave; Arka Pattanayak; Robin Parihar; Andrew R Stiff; Prashant Trikha; Steven D Scoville; Sandya Liyanarachchi; Sri Vidya Kondadasula; Omkar Lele; Ramana Davuluri; Philip R O Payne; William E Carson
Journal:  BMC Med Genomics       Date:  2015-10-15       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.